Bausch Health Companies Return on Equity

Bausch Health Companies (BHC) currently reports a ROE of 60.73%. That is above the Healthcare sector average of 20.86%. Use the charts on this page to explore Bausch Health Companies's ROE history and peer comparisons.

Bausch Health Companies's ROE of 60.73% is higher than the Healthcare sector average of 20.86%. That is roughly 191.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Bausch Health Companies's current 60.73% should be judged against Healthcare norms (sector average: 20.86%) and against BHC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 60.73%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.86%. From there, open related valuation or income-statement pages for Bausch Health Companies, and consider following BHC for alerts when major investors trade the stock.

Bausch Health Companies is classified in the Healthcare sector. On ROE, it currently shows 60.73% versus a sector average near 20.86%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BHC with unrelated industries.